Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Head Neck. 2023 Sep 8;45(11):2789–2797. doi: 10.1002/hed.27502

Table 4.

RECIST Tumor Response by Comorbidity Group

Response CCI < 1 (N=53) CCI ≥ 1 (N=36) P value
Clinical Responders (CR + PR) 17 (32%) 5 (14%) 0.05
 Complete Response (CR) 6 (11%) 2 (5.6%)
 Partial Response (PR) 11 (21%) 3 (8.3%)
 Stable Disease (SD) 12 (23%) 13 (36%)
 Progressive Disease (PD) 24 (45%) 18 (50%)

Note: Bold values are statistically significant.